Daclatasvir-based Tx Shows High Viral Clearance in Liver Transplant Patients
Researchers reported “high efficacy and an excellent safety profile” for direct-acting antiviral (DAA) combinations with daclatasvir (DCV) among transplanted patients with hepatitis C virus (HCV) infection.